0001739815-20-000001.txt : 20200219 0001739815-20-000001.hdr.sgml : 20200219 20200219151058 ACCESSION NUMBER: 0001739815-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 EFFECTIVENESS DATE: 20200219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fountain Therapeutics, Inc. CENTRAL INDEX KEY: 0001739815 IRS NUMBER: 824181770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-360904 FILM NUMBER: 20629221 BUSINESS ADDRESS: STREET 1: 1029 CATHCART WAY CITY: STANFORD STATE: CA ZIP: 94305 BUSINESS PHONE: 650-856-1971 MAIL ADDRESS: STREET 1: 1029 CATHCART WAY CITY: STANFORD STATE: CA ZIP: 94305 D 1 primary_doc.xml X0708 D LIVE 0001739815 Fountain Therapeutics, Inc. 953 Indiana St. San Francisco CA CALIFORNIA 94107 628-264-9053 DELAWARE None None Corporation true 2018 John Dimos 953 Indiana St. San Francisco CA CALIFORNIA 94107 Executive Officer Director Thomas Rando 953 Indiana St. San Francisco CA CALIFORNIA 94107 Executive Officer Director Ashish Khanna 953 Indiana St. San Francisco CA CALIFORNIA 94107 Director Biotechnology Decline to Disclose 06b false 2020-02-12 false true false 0 5999999 5999999 0 false 2 0 0 0 false Fountain Therapeutics, Inc. John Dimos John Dimos Chief Executive Officer 2020-02-19